文献速递妇科

机器人辅助与开腹间歇性肿瘤细胞减灭术治疗晚期上皮性卵巢癌的比较

Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy.
PubMed 文献 · J Minim Invasive Gynecol · 2020-11-26

单中心回顾性队列纳入93例接受新辅助化疗后行间歇性肿瘤细胞减灭术的晚期上皮性卵巢癌患者,比较机器人辅助(43例)与开腹(50例)两种术式的生存结局。两组无进展生存期与总生存期均无差异,达到R0切除可独立改善生存;在机器人辅助组中,化疗总疗程超过6个与更差的PFS和OS独立相关。

要点

  • 机器人辅助与开腹间歇性肿瘤细胞减灭术的PFS和OS无差异
  • R0切除率不受手术方式影响,R0可独立改善PFS和OS
  • 机器人辅助组中化疗总疗程>6个与PFS和OS下降独立相关

核心结论

  • 在晚期上皮性卵巢癌新辅助化疗后行间歇性肿瘤细胞减灭术的患者中,机器人辅助手术未影响减灭成功率或肿瘤学生存指标。
  • 在本队列接受机器人辅助间歇性肿瘤细胞减灭术的患者中,术前化疗总疗程超过6个与PFS和OS下降相关,值得进一步研究。

研究设计与样本

  • 单中心回顾性队列研究,2011至2018年单中心三级医疗中心。
  • 共93例晚期上皮性卵巢癌患者,均在新辅助化疗后行间歇性肿瘤细胞减灭术,其中机器人辅助43例、开腹50例。
  • 排除新辅助化疗少于3个或多于6个疗程者,以及治疗期间合并其他恶性肿瘤者。

主要发现

  • 两组中位年龄63.0岁与66.2岁,无差异(p = .1)。
  • 全部患者中91%达到满意减灭(R0 57%、R1 34%),R0率不受手术方式影响(开腹52% vs 机器人辅助63%,p = .4)。
  • 开腹与机器人辅助组的PFS(15.4 vs 16.7个月,p = .7)和OS(38.2 vs 35.6个月,p = .7)均无差异。
  • 机器人辅助组中化疗总疗程>6个与PFS下降(风险比3.85;95%CI 1.52-9.73)和OS下降(风险比3.97;95%CI 1.08-14.59)独立相关。
  • 单独分析时,新辅助化疗周期数与辅助化疗周期数对生存均无影响。

关键数值与推荐

  • R0切除可独立改善PFS和OS,且不受手术方式影响。
  • 机器人辅助组化疗总疗程>6个:PFS风险比3.85(95%CI 1.52-9.73),OS风险比3.97(95%CI 1.08-14.59)。

临床怎么用

  • 晚期上皮性卵巢癌新辅助化疗后行间歇性肿瘤细胞减灭术时,机器人辅助可作为开腹之外的术式选择,两者生存结局相当。
  • 减灭目标应争取R0切除,因其与PFS和OS改善独立相关。
  • 对计划行机器人辅助间歇性肿瘤细胞减灭术者,需关注化疗总疗程数超过6个与生存下降的关联。

局限性

  • 为单中心回顾性队列研究,样本量93例,可能存在选择偏倚。
  • 化疗总疗程>6个与生存下降的关联仅在机器人辅助组亚组分析中观察到,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Compare survival of patients with advanced epithelial ovarian cancer (EOC) undergoing interval debulking surgery (IDS) with either robot-assisted (R-IDS) or open (O-IDS) approach. Second, we assessed the impact of adjuvant and neoadjuvant chemotherapy (NACT) cycles as independent variables associated with survival in this patient population. DESIGN: Retrospective cohort study. SETTING: Single tertiary care center. PATIENTS: Total of 93 patients diagnosed with advanced EOC who underwent NACT before primary debulking surgery after consultation with a gynecologic oncologist. INTERVENTIONS: All patients underwent IDS after completion of NACT with either R-IDS or O-IDS between 2011 and 2018 at a single tertiary care center. Exclusion criteria included receiving fewer than 3 or more than 6 cycles of NACT or having concurrent diagnoses of other malignancies during the treatment period. MEASUREMENTS AND MAIN RESULTS: A total of 93 patients were identified (n = 43 R-IDS; n = 50 O-IDS). Median age (63.0 vs 66.2 years) did not differ between the 2 groups (p = .1). Of the total patients, 91% were optimally cytoreduced (57% R0 and 34% R1), and R0 rate was not influenced by surgical modality (52% O-IDS vs 63% R-IDS, p = .4). Progression-free survival (PFS) and overall survival (OS) did not differ between patients undergoing O-IDS and those undergoing R-IDS (PFS 15.4 vs 16.7 months, p = .7; OS 38.2 vs 35.6 months, p = .7). Cytoreduction to R0 improved both PFS and OS independent of surgical approach. Subgroup analysis showed that, specifically in patients undergoing R-IDS, receiving >6 total cycles of chemotherapy was independently associated with both decreased PFS (hazard ratio 3.85; 95% confidence interval, 1.52-9.73) and OS (hazard ratio 3.97; 95% confidence interval, 1.08-14.59). When analyzed separately, neither NACT nor adjuvant cycle numbers had any effect on survival. CONCLUSION: In this retrospective study of patients with advanced EOC undergoing IDS after NACT, the use of robot-assisted surgery did not affect debulking success or oncologic survival indices. Receiving >6 total cycles of chemotherapy before IDS was associated with a decrease in both PFS and OS in patients undergoing R-IDS in this cohort and warrants further investigation.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Grant MS, Zhang X, et al. Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy. J Minim Invasive Gynecol. 2020. PMID: 33248314. doi:10.1016/j.jmig.2020.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。